1 天前 - … Evidence from pediatric studies support the efficacy of antifungal prophylaxis in
reducing the burden of IFD in children receiving therapy for AML, yet existing antifungal agents …

1 天前 - … patients (91%) received antifungal therapy during hospitalization. In the multivariate
… all-cause mortality, but pre-ICU antifungal use had statistically insignificant mortality risk …

2 天前 - … Voriconazole is a broad-spectrum triazole antifungal agent. A number of studies
have … a decreased dose to attain the therapeutic trough concentration and avoid adverse drug …

2 天前 - … therapeutic failure, contributing to the mortality associated with invasive candidiasis.
Despite advances in the field of antifungal therapy, … if more effective therapeutic alternatives …

2 天前 - … timely onset of pre-emptive antifungal treatment. To address this diagnostically …
therapy, and conversely, contribute to timely employment of effective pre-emptive antifungal …

2 天前 - … fluconazole (an antifungal agent commonly used in the therapy of candidiasis),
indicating that they all have potential to be synergically applied with this antifungal agent in the …

2 天前 - … Using the Kaplan–Meier survival analysis, we compared the patients receiving and
not receiving antifungal therapy. Multiple logistic regressions were performed to determine …

2 天前 - … were put on pneumocystis and antifungal prophylaxis when immunosuppressed
with rituximab. Modeling … therapy in a cohort of patients with symptomatic and progressive FM. …

2 天前 - … This protocol can contribute to the need for initiating effective antifungal therapy
to address and manage fungal infections or mycosis in oxygen-limited environments. …

2 天前 - … possess not only biological activity but also therapeutic effects. A Schiff base complex,
… coli and Staphylococcus aureus) and antifungal (Candida albicans and Aspergillus niger…